Abiopharma

MiNK Therapeutics Reports Durable Responses and Immune Reactivation with Allo-iNKT Cell Therapy agenT-797 in PD-1–Refractory Solid Tumors at SITC 2025

Baxter - The Baxter Foundation Announces $2.6M Grant to Advance STEM Education in Chicagoland Through Partnership With Northwestern University

The Baxter Foundation Announces $2.6M Grant to Advance STEM Education in Chicagoland Through Partnership With Northwestern University

Gilead - Gilead Provides Update on Phase 3 ASCENT-07 Study

Halozyme - FDA Approved DARZALEX Faspro® for Adult Patients with High-Risk Smoldering Multiple Myeloma

New Pooled 3-Year Analysis Confirms Sustained, Clinically Meaningful Improvements in Renal Function for TransCon® PTH (Palopegteriparatide)-Treated Adults with Hypoparathyroidism

Gilead Provides Update on Phase 3 ASCENT-07 Study

Wave Life Sciences to Present at Upcoming Investor Conferences

Star Equity Holdings to Release Third Quarter 2025 Financial Results on November 13

ALX Oncology Reports Third Quarter 2025 Financial Results and Provides Corporate Update